ADP Form 144: Insider Sale of 7,721 Shares Valued at $2.33M
Form 144 notice for Automatic Data Processing, Inc. (ADP) reports a proposed sale of 7,721 common shares on 09/02/2025 through Fidelity Brokerage Services on NASDAQ.
Rhea-AI Filing Summary
Form 144 notice for Automatic Data Processing, Inc. (ADP) reports a proposed sale of 7,721 common shares on 09/02/2025 through Fidelity Brokerage Services on NASDAQ. The notice lists an aggregate market value of $2,328,962.44 and 405,043,142 shares outstanding. The securities were recorded as acquired on 09/02/2025 arising from an option granted on 09/01/2021, with payment described as cash. The filer indicates “Nothing to Report” for securities sold in the past three months. A filing field shows LIVE TEST in the submission contact section.
Positive
- Clear disclosure of broker, share count, aggregate market value, and intended sale date
- Acquisition details provided (option grant date 09/01/2021 and acquisition date 09/02/2025)
- No sales reported in the past three months, simplifying compliance aggregation
Negative
- Filing contact field shows the ambiguous entry "LIVE TEST", which may signal submission metadata issues
Insights
TL;DR: Routine insider exercise and planned sale, modest relative size versus float; likely neutral to market.
The filing documents an option exercise and concurrent planned sale of 7,721 ADP common shares valued at $2.33 million. Versus the stated outstanding share count of 405.0 million, this block represents roughly 0.0019% of shares outstanding, which is immaterial to capital structure. The disclosure complies with Rule 144 reporting by identifying acquisition date, grant date, broker, and intended sale date on NASDAQ. No prior sales in the last three months are reported, reducing the likelihood of aggregated-sale complications. Overall, this is a routine insider liquidity event with limited market impact.
TL;DR: Governance disclosure appears complete for a Rule 144 notice; representation about material nonpublic information is included.
The form includes the standard representation that the seller does not possess undisclosed material adverse information and notes plan/adoption fields relevant to Rule 10b5-1. The itemization of broker, exact share count, and payment method (cash) aligns with disclosure best practices. The presence of a field labeled "LIVE TEST" in submission contact info is an oddity but is explicitly presented in the form. No indications of unusual governance actions or material transactions are present in the notice.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the ADP Form 144 report?
Does the filer report other sales in the past three months?
What broker will execute the sale?
Does the filing include any representation about material nonpublic information?
AI-generated analysis. How Rhea-AI works. Not financial advice.